Caura

At Caura we have developed advanced micro-needle technologies to enable painless and real-time monitoring of biomolecules (starting with, but not limited to, glucose and lactic acid measurements). Initially, targetting athletic performance to help users train smarter, provide optimal dietary plans and reduce injury risk. We have scheduled trials with 10+ world-class sports and high-performance institutions including the British Rowing team, Inter Milan and the Chicago Cubs to disrupt the $38BN (CAGR:42.9%) self-health monitoring market.